Privacy Policy
2nd Liver Immunology Meeting AISF and SIICA

2nd Liver Immunology Meeting AISF and SIICA

meeting
2ndLiverimmunology2017
Data: Giovedì 16 Marzo 2017 - Sabato 18 Marzo 2017

Luogo: Università di Milano Bicocca,  |  Città: Milano, Italia

16-18 marzo 2017
2nd Liver Immunology Meeting AISF and SIICA
Università di Milano Bicocca, Piazza dell'Ateneo Nuovo 1, Milano

 

 

Day 1 (16 March 2017)

h. 15:30 Registration

h. 16:45 Welcome

P. Invernizzi | San Gerardo Hospital, Monza, and University of Milan-Bicocca, Milan, Italy

h. 17:00 State-of-the-art Lecture

Chairman:

G. Missale | University Hospital of Parma, Parma, Italy

Liver inflammation in HBV

A. Bertoletti| Institute for Clinical Sciences, Singapore

h. 18:00 Welcome Cocktail

 

Day 2 (17 March 2017)

Basic Liver Immunity

Chairs:

C. Garlanda |Humanitas Clinical and Research Center, Milano, Italy

D.Mavilio |University of Milan, Milan, and Humanitas Clinical and Research Center, Rozzano, Italy

h. 08:30 Innate immune response to liver injury

I.N. Crispe| University of Washington, Seattle, WA, USA

h. 09:00 Trafficking of CD8+ T cells within the liver

L. Guidotti| The Scripps Research Institute, La Jolla, CA, USA and San Raffaele Scientific Institute, Milan, Italy

h. 09:30 Biliary tree and the immune microenviroment: a peculiar relationship

L. Fabris|University of Padua, Padua, Italy and University of Yale, Yale, CT, USA

h. 10:00 Coffee break

h. 10:30 Mechanisms of immune mediated liver injury

D. Adams| University of Birmingham, Birmingham, UK

h. 11:00 Gut-liver axis: enterocytes drive liver protection against inflammation fibrosis and cancer

  A. Moschetta | University of Bari, Bari, Italy

h. 11:30 Crosstalk between liver fibrosis and immune system

F. Marra | University of Firenze, Firenze, Italy

h. 12:00 Three short selected presentations from submitted abstracts (not accredited CME)

M. Molgora | IL-1R8: a novel checkpoint regulating anti-tumoranti-viral activity of NK cells

A. Bènèchet | Spatiotemporal dynamics of naïve CD8+ T cells undergoing intrahepatic priming

S. Bruzzì | Role of cx3cr1 in the differentiation of monocyte-derived inflammatory dendritic cells in response to hepatic injury 

h. 12:45 Lunch and poster viewing

 

Virus and Liver cancer

Chairs:

M. Mondelli| University of Pavia, Pavia, Italy

S. Abrignani | Istituto di Genetica Molecolare, Milan, Italy

h. 14:00 NK cells good or bad for chronic HBV infection

M. Maini | University College London, London, UK

h. 14:30 Novel immunotherapeutic strategies for HBV infection

C. Ferrari| University Hospital of Parma, Parma, Italy

h. 15:00 Immunotherapeutic strategies for chronic HCV infection

A. Folgori|Okairos, Rome, Italy

h. 15:30 DAAs for HCV infection which role for the immune system

R. Thimme|University Hospital Freiburg, Freiburg, Germany

h. 16:00 Coffee break

h. 16:20 Hepatocellular carcinoma proteome: inhibitory mechanisms of T-cell response

V. Barnaba | University of Rome La Sapienza, Rome, Italy

h. 16:50 NK cells in hepatocellular Carcinoma

G. Missale| University Hospital of Parma, Italy

h. 17:20 Immunotherapy of hepatocellular carcinoma: immunomodulation with monoclonal antibodies

I. Melero | CIMA, CUN and Medical School, University of Navarra, Pamplona, Spain

h. 17:50 New insights into pathogenesis and treatment of HCV-related B cell clonal disorders

V. Racanelli | University of Bari, Bari, Italy

h. 18:20 Three short selected presentations from submitted abstracts (not accredited CME)

M. Visentini | Reversion of B-cell anergy in patients with Hepatitis C virus-associated mixed cryoglobulinemia after removal of chronic antigen stimulation – a model of human reversible peripheral B cell anergy?

E. Cariani | Prognostic correlates of the immune microenvironment of hepatocellular carcinomasurrounding liver

E. Riboldi | Role of CLEC4D in inflammation-driven liver carcinogenesis

 

Day 3 (18 March 2017) 

Autoimmunity

Chairs:

E. Krawitt | University of Vermont, Burlington, VT, USA

A. Tanaka | Teikyo University, Tokyo, Japan

h. 08:30 Geographical differences in autoimmune liver diseases

X. Ma | Shanghai Institute of Digestive Disease, Shanghai, China

h. 09:00 Role of interferons in autoimmune liver diseases: lesson from animal models

H. Young| National Institute of Health, Bethesta, MD, USA

h. 09:30 Primary biliary cholangitis

M.E. Gershwin | University of California, Davis, CA, USA

h. 10:00 Coffee break


h. 10:20
 
Risk stratification in primary biliary cholangitis

M. Carbone | San Gerardo Hospital, Monza, and University of Milan-Bicocca, Milan, Italy

h. 10:50 Unmet clinical needs in autoimmune hepatitis

C. Schramm| University of Hamburg, Hamburg, Germany

h. 11:20 Unmet clinical needs in primary sclerosing cholangitis

C. Bowlus | University of California, Davis, CA, US

h. 11:50 Three short selected presentations from submitted abstracts (Not accredited CME)

M. B. Violatto | NP-dependent administration of dexamethasone prevents its systemic spreadreduces inflammatory markers in a murine model of autoimmune hepatitis.

S. Pang | Prevalence of autoimmune liver disease-related autoantibodies in patients with biliary artesia

A. Gerussi | Incomplete normalization of transaminases at 18 months is the most important predictor for biochemical response

h. 12:35 Round table: Novel therapeutic approaches for pediatric and adult autoimmune liver diseases

Chairman:

P. Invernizzi | San Gerardo Hospital, Monza, and University of Milan-Bicocca, Milan, Italy

Discussants:

A. Floreani | University of Padua, Padua, Italy

L. Muratori | University of Bologna, Bologna, Italy

A. Tanaka | Teikyo University, Tokyo, Japan

h. 13:30 Lunch and poster viewing

h. 14:30 State-of-the-art Lecture

Chairman: 

A. Biondi | University of Milan-Bicocca, Milan, Italy

Gut-liver axis in liver disease

M. Rescigno | IFOM-IEO, Istituto Europeo di Oncologia and University of Milano, Milan, Italy

 

Luogo
Piazza dell'Ateneo Nuovo, 1
20126 Milano, Italia

 

Google Maps


 

Altre date


  • Da Giovedì 16 Marzo 2017 a Sabato 18 Marzo 2017

Powered by iCagenda